These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30101193)

  • 1. Unexpected contribution of lymphatic vessels to promotion of distant metastatic tumor spread.
    Ma Q; Dieterich LC; Ikenberg K; Bachmann SB; Mangana J; Proulx ST; Amann VC; Levesque MP; Dummer R; Baluk P; McDonald DM; Detmar M
    Sci Adv; 2018 Aug; 4(8):eaat4758. PubMed ID: 30101193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular control of lymphatic metastasis.
    Achen MG; Stacker SA
    Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor superfamily 15 promotes lymphatic metastasis via upregulation of vascular endothelial growth factor-C in a mouse model of lung cancer.
    Qin T; Huang D; Liu Z; Zhang X; Jia Y; Xian CJ; Li K
    Cancer Sci; 2018 Aug; 109(8):2469-2478. PubMed ID: 29890027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of FLT4 suppresses metastasis of melanoma cells by impaired lymphatic vessels.
    Lee JY; Hong SH; Shin M; Heo HR; Jang IH
    Biochem Biophys Res Commun; 2016 Sep; 478(2):733-8. PubMed ID: 27507214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
    Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
    Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients.
    Zhao YC; Ni XJ; Li Y; Dai M; Yuan ZX; Zhu YY; Luo CY
    World J Surg Oncol; 2012 Aug; 10():165. PubMed ID: 22906075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.
    He Y; Kozaki K; Karpanen T; Koshikawa K; Yla-Herttuala S; Takahashi T; Alitalo K
    J Natl Cancer Inst; 2002 Jun; 94(11):819-25. PubMed ID: 12048269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and clinical significance of extracellular matrix protein 1 and vascular endothelial growth factor-C in lymphatic metastasis of human breast cancer.
    Wu QW; She HQ; Liang J; Huang YF; Yang QM; Yang QL; Zhang ZM
    BMC Cancer; 2012 Jan; 12():47. PubMed ID: 22284579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial nitric oxide synthase mediates lymphangiogenesis and lymphatic metastasis.
    Lahdenranta J; Hagendoorn J; Padera TP; Hoshida T; Nelson G; Kashiwagi S; Jain RK; Fukumura D
    Cancer Res; 2009 Apr; 69(7):2801-8. PubMed ID: 19318557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct roles of vascular endothelial growth factor-D in lymphangiogenesis and metastasis.
    Kopfstein L; Veikkola T; Djonov VG; Baeriswyl V; Schomber T; Strittmatter K; Stacker SA; Achen MG; Alitalo K; Christofori G
    Am J Pathol; 2007 Apr; 170(4):1348-61. PubMed ID: 17392173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2.
    Roberts N; Kloos B; Cassella M; Podgrabinska S; Persaud K; Wu Y; Pytowski B; Skobe M
    Cancer Res; 2006 Mar; 66(5):2650-7. PubMed ID: 16510584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor-C induces lymphangitic carcinomatosis, an extremely aggressive form of lung metastases.
    Das S; Ladell DS; Podgrabinska S; Ponomarev V; Nagi C; Fallon JT; Skobe M
    Cancer Res; 2010 Mar; 70(5):1814-24. PubMed ID: 20179201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor lymphangiogenesis and melanoma metastasis.
    Rinderknecht M; Detmar M
    J Cell Physiol; 2008 Aug; 216(2):347-54. PubMed ID: 18481261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of VEGFR-3 activation in tumor-draining lymph nodes suppresses the outgrowth of lymph node metastases in the MT-450 syngeneic rat breast cancer model.
    Quagliata L; Klusmeier S; Cremers N; Pytowski B; Harvey A; Pettis RJ; Thiele W; Sleeman JP
    Clin Exp Metastasis; 2014 Mar; 31(3):351-65. PubMed ID: 24379135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.
    García-Caballero M; Paupert J; Blacher S; Van de Velde M; Quesada AR; Medina MA; Noël A
    J Hematol Oncol; 2017 Jun; 10(1):122. PubMed ID: 28629427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix.
    Gombos Z; Xu X; Chu CS; Zhang PJ; Acs G
    Clin Cancer Res; 2005 Dec; 11(23):8364-71. PubMed ID: 16322297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer.
    Wang CA; Jedlicka P; Patrick AN; Micalizzi DS; Lemmer KC; Deitsch E; Casás-Selves M; Harrell JC; Ford HL
    J Clin Invest; 2012 May; 122(5):1895-906. PubMed ID: 22466647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of vascular endothelial growth factors (VEGF)-A, -C and -D and their prognostic significance and relationship with angio- and lymphangiogenesis in gastric cancer].
    Wang XL; Ai ZS; Fang JP; Tang RY; Chen XM
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):837-43. PubMed ID: 19173829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors.
    Mattila MM; Ruohola JK; Karpanen T; Jackson DG; Alitalo K; Härkönen PL
    Int J Cancer; 2002 Apr; 98(6):946-51. PubMed ID: 11948478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A heparin conjugate, LHbisD4, inhibits lymphangiogenesis and attenuates lymph node metastasis by blocking VEGF-C signaling pathway.
    Choi JU; Chung SW; Al-Hilal TA; Alam F; Park J; Mahmud F; Jeong JH; Kim SY; Byun Y
    Biomaterials; 2017 Sep; 139():56-66. PubMed ID: 28586719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.